Qiming Capital and Hillhouse Capital have led a US$55 million series C round in Jacobio Pharmaceuticals, a Beijing-based clinical stage biotech company.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 2 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription!
Enjoy comprehensive and exclusive data you can't find elsewhere!More Info
Already have an account or paid subscription?